Evidence map›Paper›PMID 31168770›Full record

ArticleClinical pharmacokinetics2019

Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill Children.

Fanuel T Hagos, Christopher M Horvat, Alicia K Au, Yvette P Conley, Lingjue Li, Samuel M Poloyac, Patrick M Kochanek, Robert S B Clark, Philip E Empey

Open access · bronzeAbstract read
In one paragraph

Article in Clinical pharmacokinetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. The Rise of Fentanyl: Molecular Aspects and Forensic Investigations.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Fanuel T HagosCenter for Clinical Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA.
Christopher M HorvatDepartment of Critical Care Medicine, University of Pittsburgh, School of Medicine and Children's Hospital of Pittsburgh of UPMC, 4401 Penn Ave, Faculty Pavilion Suite 2000, Pittsburgh, PA, 1524, USA. Christopher.horvat@chp.edu.ORCID 0000-0002-1593-2252
Alicia K AuDepartment of Critical Care Medicine, University of Pittsburgh, School of Medicine and Children's Hospital of Pittsburgh of UPMC, 4401 Penn Ave, Faculty Pavilion Suite 2000, Pittsburgh, PA, 1524, USA.
Yvette P ConleyDepartment of Health Promotion and Development, University of Pittsburgh School of Nursing, Pittsburgh, PA, USA.
Lingjue LiSafar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, PA, USA.
Samuel M PoloyacSafar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, PA, USA.
Patrick M KochanekDepartment of Critical Care Medicine, University of Pittsburgh, School of Medicine and Children's Hospital of Pittsburgh of UPMC, 4401 Penn Ave, Faculty Pavilion Suite 2000, Pittsburgh, PA, 1524, USA.
Robert S B ClarkDepartment of Critical Care Medicine, University of Pittsburgh, School of Medicine and Children's Hospital of Pittsburgh of UPMC, 4401 Penn Ave, Faculty Pavilion Suite 2000, Pittsburgh, PA, 1524, USA.
Philip E EmpeySafar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, PA, USA.
University of Pittsburgh · US

Funding

NRSA Training CoreTL1TR001858 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RADOMSKI, THOMAS, RUBIO, DORIS M · 2016 to 2025
$11.1M
PEDIATRIC NEUROINTENSIVE CARE AND RESUSCITATION RESEARCHT32HD040686 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Robert S B Clark, PATRICK M KOCHANEK · 2000 to 2026
$7.1M
Mixed graphical models for the prediction of neurological morbidity in the PICUK23NS104133 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AU, ALICIA K · 2018 to 2022
$947k
NCATS NIH HHS TL1 TR001858NICHD NIH HHS L40 HD099798NICHD NIH HHS T32 HD040686NINDS NIH HHS K23 NS104133
6 · The paper itself

Abstract

objectiveThe objective of this study was to characterize the population pharmacokinetics of fentanyl and identify factors that contribute to exposure variability in critically ill pediatric patients.

methodsWe conducted a single-center, retrospective cohort study using electronic record data and remnant blood samples in the setting of a mixed medical/surgical intensive care unit (ICU) at a quaternary children's hospital. Children with a predicted ICU length of stay of at least 3 days and presence of an indwelling central venous or arterial line were included. Serum fentanyl measurements were performed for 278 unique remnant samples from 66 patients. Both one- and two-compartment models were evaluated to describe fentanyl disposition. Covariates were introduced into the model in a forward/backward, stepwise approach and included age, sex, race, weight, cytochrome P450 (CYP) 3A5 genotype, and the presence of CYP3A4 or CYP3A5 inducers or inhibitors. Simulations were performed using the successful model to depict the influence of inducers on fentanyl concentrations.

resultsA two-compartment base model best described the data. There was good agreement between observed and predicted concentrations in the final model. The typical fentanyl clearance for 70 kg (reference weight) and 20.1 kg (median weight) patients were 34.6 and 13.6 L/h, respectively. The magnitude of the unexplained random inter-individual variability was high for both clearance (60.7%) and apparent volume of the central compartment (V

conclusionsIn this study we show the feasibility and utility of using electronic record data and remnant blood samples to successfully construct population pharmacokinetic models for a heterogeneous cohort of critically ill children. A clinically relevant effect of concomitant CYP3A4/5 inducers was identified. Scaling this population pharmacokinetic approach is necessary to craft precision approaches to fentanyl administration for critically ill children.

Indexed as

Critical IllnessModels, BiologicalAdolescentAnalgesics, OpioidChildChild, PreschoolCohort StudiesFemaleFentanylHospitals, PediatricHumansInfantIntensive Care Units, PediatricLength of StayMaleRetrospective StudiesAnalgesics, OpioidFentanyl

Identifiers

PMID31168770
PMCPMC7122686
OpenAlexW2957595678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.